Timolol and Zetia drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Timolol (timolol) and Zetia (ezetimibe). Common drug interactions include migraine with aura among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Timolol and Zetia. It is created by eHealthMe based on reports of 53 people who take the same drugs from the FDA, and is updated regularly.

What is Timolol?

Timolol has active ingredients of timolol. It is often used in glaucoma. eHealthMe is studying from 9,142 Timolol users. Check the latest studies of Timolol.

What is Zetia?

Zetia has active ingredients of ezetimibe. It is often used in high blood cholesterol. eHealthMe is studying from 49,113 Zetia users. Check the latest studies of Zetia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 20, 2026

53 people who take Timolol and Zetia together, and have interactions are studied.

Timolol and Zetia drug interactions.

What are the common drug interactions of Timolol and Zetia, by gender? *:

female:

  1. Migraine with aura (headache with vision weakness)
  2. Mobility decreased (ability to move is reduced)
  3. Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
  4. Myalgia (muscle pain)
  5. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  6. Nasopharyngitis (inflammation of the nasopharynx)
  7. Nausea (feeling of having an urge to vomit)
  8. Nephrogenic anaemia (anaemia due to kidney disease)
  9. Nephropathy (damage to or disease of a kidney)
  10. Nervousness

male:

  1. Chronic kidney disease
  2. Death
  3. Ageusia (loss of taste functions of the tongue)
  4. Ammonia increased
  5. Anosmia (partial or complete loss of the sense of smell)
  6. Anxiety
  7. Atelectasis (partial or complete collapse of the lung)
  8. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  9. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  10. Confusional state

What are the common drug interactions of Timolol and Zetia, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Anxiety
  4. Depression
  5. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  6. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  7. Nephrogenic anaemia (anaemia due to kidney disease)
  8. Nephropathy (damage to or disease of a kidney)

50-59:

  1. Back pain
  2. Low density lipoprotein increased (cholesterol increased in blood)
  3. Nerve injury
  4. Pain
  5. Pain in extremity
  6. Anxiety
  7. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  8. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  9. Heart valve incompetence (heart's valves do not work correctly)
  10. Type 2 diabetes mellitus

60+:

  1. Chronic kidney disease
  2. Diarrhoea
  3. Adverse event
  4. Ageusia (loss of taste functions of the tongue)
  5. Ammonia increased
  6. Angina pectoris (chest pain due to ischemia of the heart muscle)
  7. Anosmia (partial or complete loss of the sense of smell)
  8. Asthenia (weakness)
  9. Atelectasis (partial or complete collapse of the lung)
  10. Balance disorder

What are the existing conditions these people have? *

  1. Primary Myelofibrosis (primary disorder of the bone marrow): 11 people, 20.75%
  2. Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 10 people, 18.87%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 9 people, 16.98%
  4. Pain: 7 people, 13.21%
  5. High Blood Pressure: 7 people, 13.21%
  6. Type 2 Diabetes: 6 people, 11.32%
  7. Stress And Anxiety: 6 people, 11.32%
  8. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 9.43%
  9. Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 5.66%
  10. Headache (pain in head): 3 people, 5.66%

* Approximation only. Some reports may have incomplete information.

Do you take Timolol and Zetia?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Timolol and Zetia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Timolol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Zetia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Timolol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zetia and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on timolol and ezetimibe (the active ingredients of Timolol and Zetia, respectively), and Timolol and Zetia (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: